Loading...
Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization
BACKGROUND: Neuroimaging measures and chemical biomarkers may be important indices of clinical progression in normal aging and mild cognitive impairment (MCI) and need to be evaluated longitudinally. OBJECTIVE: To characterize cross-sectionally and longitudinally clinical measures in normal controls...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Academy of Neurology
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2809036/ https://ncbi.nlm.nih.gov/pubmed/20042704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181cb3e25 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|